Special Bulletin: CMS Issues Interim Final Rule Implementing Most Favored Nation Model for Part B Drugs

November 23, 2020

The Centers for Medicare & Medicaid Services (CMS) Nov. 20 released an interim final rule implementing the Most Favored Nation (MFN) Model, a new payment model through the Center for Medicare and Medicaid Innovation (CMMI) that will cut Medicare Part B payments for certain drugs to the lowest price available in similar countries.

Starting Jan. 1, the MFN Model will no longer pay an average sales price (ASP)-based rate for certain high-cost, separately payable Medicare Part B drugs. Instead, it will pay no more than the lowest price charged in other similar countries for these drugs. The model also will pay providers a flat add-on amount for each dose of an MFN drug, instead of a percentage of each drug’s ASP as is currently the case. Medicare beneficiaries will not pay coinsurance on the add-on payment.

The scope of the MFN Model is nationwide – that is, participation is required by all Medicare providers and suppliers that receive separate Medicare Part B fee-for-service payment for the model’s included drugs, with certain exceptions.

AHA members must log in to access this Special Bulletin.

View Special Bulletin

Related Resources

Action Alert
Member
AHA urges hospital and health system leaders to contact their senators and representatives and urge them not to use unobligated COVID-19 Provider Relief Funds…
Special Bulletin
Public
Download the AHA Special Bulletin: CMS Issues Hospital Outpatient/ASC Proposed Rule, Including Modifications to Price Transparency Rule
Advisory
Member
On June 28, the Centers for Medicare…
Letter/Comment
Public
Congress should not extend Medicare sequestration to help pay for the bipartisan infrastructure framework because health care providers cannot sustain…
Special Bulletin
Public
The Centers for Medicare…
Action Alert
Member
Congress and the Biden Administration continue to prepare legislative language for a roughly $1.2 trillion infrastructure package as part of an agreement…